| Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ... Journal of hepatology 71 (2), 265-273, 2019 | 165 | 2019 |
| Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome C Efe, AV Kulkarni, BT Beretta‐Piccoli, B Magro, A Stättermayer, ... Hepatology 76 (6), 1576-1586, 2022 | 85 | 2022 |
| Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysis M Tacelli, C Celsa, B Magro, M Barchiesi, L Barresi, G Capurso, ... Digestive Endoscopy 32 (7), 1018-1030, 2020 | 67 | 2020 |
| Antidiabetic drugs in NAFLD: the accomplishment of two goals at once? M Tacelli, C Celsa, B Magro, A Giannetti, G Pennisi, F Spatola, S Petta Pharmaceuticals 11 (4), 121, 2018 | 64 | 2018 |
| Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy A Di Giorgio, E Nicastro, C Speziani, M De Giorgio, L Pasulo, B Magro, ... Journal of hepatology 73 (3), 702, 2020 | 55 | 2020 |
| Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: systematic review and meta-analysis M Tacelli, C Celsa, B Magro, L Barresi, S Guastella, G Capurso, L Frulloni, ... Clinical Gastroenterology and Hepatology 17 (6), 1061-1072. e8, 2019 | 53 | 2019 |
| Biliary complications after liver transplantation: current perspectives and future strategies B Magro, M Tacelli, A Mazzola, F Conti, C Celsa Hepatobiliary Surgery and Nutrition 10 (1), 76, 2021 | 44 | 2021 |
| Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use B Magro, V Zuccaro, L Novelli, L Zileri, C Celsa, F Raimondi, M Gori, ... PloS one 16 (1), e0245281, 2021 | 34 | 2021 |
| Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis C Efe, C Lammert, K Taşçılar, R Dhanasekaran, B Ebik, ... Liver international 42 (3), 607-614, 2022 | 32 | 2022 |
| Rete Sicilia Selezione Terapia–HCV (RESIST-HCV) and Italian Liver Cancer (ITA. LI. CA.) Group. Direct-acting antivirals after successful treatment of early hepatocellular … G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ... J Hepatol 71 (2), 265-273, 2019 | 25 | 2019 |
| Acute liver failure and HELLP syndrome: A clinical case and literature review A Mazzola, B Magro, F Perdigao, F Charlotte, M Atif, C Goumard, ... Clinics and Research in Hepatology and Gastroenterology 45 (2), 101498, 2021 | 14 | 2021 |
| Point‐of‐care HCV RNA testing in the setting of DAA therapy: HCV‐FiS (HEpatitis C Virus Fingerstick Study) V Calvaruso, F Bronte, D Ferraro, G Reina, E Conte, F Rini, B Magro, ... Liver International 39 (12), 2240-2243, 2019 | 14 | 2019 |
| Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study A Mazzola, R Brustia, B Magro, M Atif, N Ouali, J Tourret, B Barrou, ... Clinics and Research in Hepatology and Gastroenterology 45 (4), 101692, 2021 | 13 | 2021 |
| Donor simvastatin treatment is safe and might improve outcomes after liver transplantation: a randomized clinical trial D Pagano, J Bosch, F Tuzzolino, E Oliva, B Ekser, G Zito, D Cintorino, ... Transplantation 106 (12), 2379-2390, 2022 | 9 | 2022 |
| Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination C Rigamonti, B Coco, M Brunetto, S Labanca, EG Giannini, B Magro, ... Digestive and Liver Disease 54, S48, 2022 | 7 | 2022 |
| Pre-transplant alpha-fetoprotein> 25.5 and its dynamic on waitlist are predictors of HCC recurrence after liver transplantation for patients meeting Milan criteria B Magro, D Pinelli, M De Giorgio, MG Lucà, A Ghirardi, A Carrobio, ... Cancers 13 (23), 5976, 2021 | 7 | 2021 |
| Consequences of Extended Spectrum Beta‐Lactamase–Producing Enterobacteriaceae and Methicillin‐Resistant Staphylococcus aureus Carriage in Awaiting … B Magro, A Mazzola, M Munteanu, C Goumard, V Martinez, D Bernard, ... Liver Transplantation 27 (1), 43-54, 2021 | 7 | 2021 |
| N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity … C Efe, C Lammert, K Taşçılar, R Dhanasekaran, B Ebik, ... Liver Int 42, 607-614, 2022 | 6 | 2022 |
| Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients M Gori, C Berzuini, E D’Elia, A Ghirardi, L Bernardinelli, A Gavazzi, ... Journal of hypertension 40 (4), 666-674, 2022 | 5 | 2022 |
| Association between inhibitors of the renin–angiotensin system and lung function in elderly patients recovered from severe COVID-19 M Gori, A Ghirardi, E D’Elia, G Imeri, F Di Marco, A Gavazzi, A Carobbio, ... European Journal of Preventive Cardiology 29 (5), e196-e199, 2022 | 4 | 2022 |
